Astellas Pharma Inc.

In News

Astellas Careers: Work With Purpose in Science & Innovation - Astellas

Astellas - Oct 07, 2025

Why analysts recommend Astellas Pharma Inc. (YPH) stock - 2025 Market Trends & Community Consensus Stock Picks - Newser

Newser - Dec 04, 2025

Astellas Pharma Inc. to Present New Data on XOSPATA (Gilteritinib) Across the FLT3m+ AML Disease Continuum At ASH 2025 Annual Meeting - marketscreener.com

marketscreener.com - Dec 05, 2025

Astellas Pharma (TSE:4503) Will Pay A Dividend Of ¥39.00 - simplywall.st

simplywall.st - Dec 04, 2025

Astellas Announces Top Management Personnel Change - PR Newswire

PR Newswire - Sep 29, 2025

Pfizer Inc. (PFE) and Astellas Pharma Announce Survival Results from Phase 3 EMBARK Study - Yahoo Finance

Yahoo Finance - Oct 26, 2025

Astellas To Present New Data on XOSPATA™ (gilteritinib) Across the FLT3m+ AML Disease Continuum at ASH 2025 Annual Meeting - BioSpace

BioSpace - Dec 05, 2025

Astellas Pharma Inc. 2026 Q1 - Results - Earnings Call Presentation (OTCMKTS:ALPMF) 2025-08-08 - Seeking Alpha

Seeking Alpha - Aug 08, 2025

Astellas Annual Integrated Report - Astellas

Astellas - Oct 07, 2025

Astellas Enters Exclusive License Agreement with Evopoint Biosciences for XNW27011, a Novel Clinical-stage Antibody-Drug Conjugate Targeting CLDN18.2 - PR Newswire

PR Newswire - May 29, 2025

FDA Expands PADCEV Combo Approval and It Might Change the Case for Investing in Astellas Pharma (TSE:4503) - simplywall.st

simplywall.st - Dec 02, 2025

Our People - Astellas

Astellas - Oct 07, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment